CP 24,879 (hydrochloride) – 50 mg

Brand:
Cayman
CAS:
10141-51-2
Storage:
-20
UN-No:
Non-Hazardous - /

Essential fatty acid deficiency symptoms include immune system depression and a general state of inflammatory inhibition. CP 24,879 is an inhibitor of arachidonic acid biosynthesis acting via the inhibition of Δ5/Δ6 desaturase.{10907} Mice injected with CP 24,879 at 3 mg/kg had a reduction of liver arachidonate content of approximately 50%. Murine mastocytoma cells treated with 5 µM CP 24,879 showed increased mead acid content and nearly complete ablation of leukotriene C4 synthesis, consistent with a desaturase inhibition-induced state of essential fatty acid deficiency.{10906}  

 

Available on backorder

SKU: 10120 - 50 mg Category:

Description

Essential fatty acid deficiency symptoms include immune system depression and a general state of inflammatory inhibition. CP 24,879 is an inhibitor of arachidonic acid biosynthesis acting via the inhibition of .DELTA.5/.DELTA.6 desaturase.{10907} Mice injected with CP 24,879 at 3 mg/kg had a reduction of liver arachidonate content of approximately 50%. Murine mastocytoma cells treated with 5 µM CP 24,879 showed increased mead acid content and nearly complete ablation of LTC4 synthesis, consistent with a desaturase inhibition-induced state of essential fatty acid deficiency.{10906}


Formal name: 4-(3-methylbutoxy)-benzenamine, monohydrochloride

Synonyms:  p-(Isopentyloxy)-aniline

Molecular weight: 215.8

CAS: 10141-51-2

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Fatty Acid Metabolism||Product Type|Biochemicals|Small Molecule Inhibitors|Sphingolipid Turnover||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Leukotrienes